eco-health
Cynthia Canyon
eco
Creelman assesses and adjusts the current frequencies in the author’s personal rife machine program.
have a history of autoimmune to deal with the physical and The machines are easily built, reactivity to treatments that mental demands of writing easily shared, can be used are intended to help. Rife is no fiction. In the last year and a exception, although overall, half I have written 800 pages repeatedly, and are versatile enough these reactions have lessened of intensely researched work. to potentially treat several diseases. as I’ve used the rife machine. Almost immediately after I So part of the dance involves began working with the rife machine I also started reading again, polishing off books ten paying close attention to my body, and having the patience times faster than I did during all of the past decade in which I to troubleshoot with a practitioner who takes my experience was sick. The number of my symptoms that have disappeared seriously to find a workable program. or abated would be too long to list here. Through rife treatment I have also experienced relief from symptoms of other The Future of Rife Technology At this point all rife treatment is subjective, which is why I pathogens, such as strep and various bacteria. I have not experienced rife technology as a magic bullet, feel so urgent that rife technology, as a treatment for Lyme, however. Not yet, anyway. To be fair, mine has been a par- requires a great deal of objective research. One way to estabticularly difficult case. Like many people with Lyme Disease, I lish the technology’s effectiveness is to study simpler dis62 ecotrendsource.com
eases such as malaria, where research indicates a promising response to rife technology. In the absence of effective Lyme treatment, there are serious workforce and health care delivery problems from the unmanageable numbers of people who are seriously ill from this and other epidemics. I do believe in the potential of the machine. I have seen it work wonders with simpler diseases—two days of running a few minutes of one frequency can knock out a flu that I would otherwise need acupuncture, a bottle of herbs, and a week in bed to clear—and it is one of the few approaches that seems versatile enough to treat Lyme without being outsmarted by the disease. At this point I see no other way I could function or have any quality of life without the rife machine. And when symptoms disappear that I have been battling for years, the machine is a real blessing. Another promise of the machine is its apparent ability to not only clear pathogens but also to strengthen acupuncture points, which can possibly help correct underlying systemic weaknesses. These weaknesses contribute to vulnerability to Lyme and other diseases. As Creelman explores this holistic direction, I have noticed a palpable relief from lifelong health issues, and an increase in my core strength. Creelman’s research has already contributed much to the field, but many other minds are needed to explore this uncharted territory. This approach could improve quality of life for potentially hundreds of thousands of people. Currently rife technology does not meet FDA standards for approval, due to the lack of objective evidence to support it. If one solely examined the limited research on rife machines, dismissing the potential of this technology is understandable. However, anyone who researches the sheer numbers and quality of testimonials about rife machines, it is hard for me to imagine coming to a conclusion other than that rife machines warrant further investigation. As one lay author put it who had interviewed countless people with late-stage Lyme, “By and large, what I found was that a Lyme sufferer had one out of two possible stories: Either, ‘I’m well because of the machines,’ or ‘I’m still suffering.’” Rife machines must be used at the patient’s own discretion, and much is still not understood about the machine. No corporation with enough funding to get FDA approval
of the machines has invested in the necessary research (FDA trials can cost $10 million or more). Western medicine is focused on drug research and production rather than alternative modalities. According to Marcia Angell, former Editor in Chief of the New England Journal of Medicine, “The most startling fact about 2002 is that the combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion).” This model is hardly sustainable as we move into the future. Rife technology, on the other hand, is hard to patent and profit from because the machines are easily built, easily shared, can be used repeatedly, and are versatile enough to potentially treat several diseases. A machine design can be patented, but electricity cannot, so it is impossible to create a monopoly and mark up the price 1,000 percent. I find it unlikely that it will find its way into mainstream medicine any time soon. The lack of FDA approval means medical doctors are not allowed to tell their patients abo ut rife machines as a treatment option—even though, of the 39 percent of Lyme Literate Medical Doctors (LLMDs) who know about rife technology, 77 percent think it is effective in treating Lyme. Furthermore, rife technology is viable, even lacking FDA approval. Any non-pharmaceutical supplement in the U.S., such as herbs, vitamins, and minerals, bears the label, “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.” Millions of alternative health care participants understand the risks of any treatment not approved by the FDA, as well as the potential benefits of those treatments. I believe doctors and alternative practitioners should conduct serious research to build knowledge about this field, and make that research public, which would place more power in the hands of patients who were better able to make informed choices about their care. Perhaps the biggest hope presented by rife machines is this: if they are part of a revolution in effective treatment, then they might contribute to a medical culture that cannot be profit-driven, because it is based on affordable, resource-wise, shared solutions. ecotrendsource.com 63